1. Home
  2. NVAX vs DSGR Comparison

NVAX vs DSGR Comparison

Compare NVAX & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • DSGR
  • Stock Information
  • Founded
  • NVAX 1987
  • DSGR 1952
  • Country
  • NVAX United States
  • DSGR United States
  • Employees
  • NVAX N/A
  • DSGR N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • DSGR Industrial Machinery/Components
  • Sector
  • NVAX Health Care
  • DSGR Industrials
  • Exchange
  • NVAX Nasdaq
  • DSGR Nasdaq
  • Market Cap
  • NVAX 1.3B
  • DSGR 1.4B
  • IPO Year
  • NVAX 1995
  • DSGR N/A
  • Fundamental
  • Price
  • NVAX $6.56
  • DSGR $28.92
  • Analyst Decision
  • NVAX Buy
  • DSGR Buy
  • Analyst Count
  • NVAX 6
  • DSGR 2
  • Target Price
  • NVAX $15.33
  • DSGR $40.50
  • AVG Volume (30 Days)
  • NVAX 5.1M
  • DSGR 53.8K
  • Earning Date
  • NVAX 08-06-2025
  • DSGR 07-31-2025
  • Dividend Yield
  • NVAX N/A
  • DSGR N/A
  • EPS Growth
  • NVAX N/A
  • DSGR N/A
  • EPS
  • NVAX 2.97
  • DSGR 0.08
  • Revenue
  • NVAX $1,254,962,000.00
  • DSGR $1,928,948,000.00
  • Revenue This Year
  • NVAX $52.02
  • DSGR $10.80
  • Revenue Next Year
  • NVAX N/A
  • DSGR $4.10
  • P/E Ratio
  • NVAX $2.21
  • DSGR $314.15
  • Revenue Growth
  • NVAX 25.92
  • DSGR 13.48
  • 52 Week Low
  • NVAX $5.01
  • DSGR $21.87
  • 52 Week High
  • NVAX $15.22
  • DSGR $41.47
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 40.82
  • DSGR 51.59
  • Support Level
  • NVAX $6.93
  • DSGR $28.48
  • Resistance Level
  • NVAX $8.46
  • DSGR $31.98
  • Average True Range (ATR)
  • NVAX 0.34
  • DSGR 1.00
  • MACD
  • NVAX -0.08
  • DSGR -0.02
  • Stochastic Oscillator
  • NVAX 9.52
  • DSGR 29.82

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About DSGR Distribution Solutions Group Inc.

Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education and medical industries.

Share on Social Networks: